"Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell...

"Executive Summary Paraganglioma Treatment Market :   This Paraganglioma Treatment Market business report is an analytical consideration of the prime challenges that may arrive in the market in terms of sales, export, import, or revenue. This market report is a comprehensive analysis on the study of  industry that gives number of market insights. This market research...

The global CRISPR technology market is entering a high-growth phase, underpinned by gene-editing breakthroughs, precision medicine, and strong public–private investment. Valued at around USD 3.6 billion in 2025 and projected to reach nearly USD 8.0 billion by 2033, the market is expected to grow at a CAGR of about 10.8% over 2025–2033.​ Browse Detailed Summary of Research...

The latest market report entitled AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034  launched by Polaris Market Research contains summarized information of the market growth through the segmentations by types and applications. Also, the report...

"Executive Summary Anti-Cancer Drug Market Size, Share, and Competitive Landscape Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. This Anti-Cancer Drug Market report has been generated...

"Executive Summary Asia-Pacific Cancer Diagnostics Market Research: Share and Size Intelligence Asia-Pacific cancer diagnostics market is expected to witness market growth at a rate of 7.5% in the forecast period of 2022 to 2029. Best-practice models and research methodologies have been employed in the reliable Asia-Pacific Cancer Diagnostics Market report for a complete market...

The Bile Duct Cancer Market is advancing steadily, fueled by precision medicine and regulatory approvals. Valued at USD 230.31 million in 2024, the market is projected to reach USD 410.76 million by 2032, expanding at a compound annual growth rate (CAGR) of 7.50% from 2025 to 2032. This article delves into market dynamics, segmentation, drivers, challenges, and competitive landscape,...

Breast Cancer Liquid Biopsy Market Set for Rapid Expansion as Non-Invasive Diagnostics Gain Traction Breast Cancer Liquid Biopsy Market was valued at approximately USD 1.17 billion in 2024 and is expected to grow robustly over the coming years due to rising breast cancer prevalence, increasing demand for early detection and disease monitoring, and growing clinical acceptance of...

Breast Cancer Liquid Biopsy Market, estimated at around USD 330.8 million in 2024, is projected to expand at a robust compound annual growth rate (CAGR) of over 21%, driven by the rising incidence of breast cancer globally and increasing adoption of non-invasive diagnostics using circulating tumor DNA (ctDNA) and other biomarkers. To delve deeper into this research, kindly...

Executive Summary Breast Cancer Liquid Biopsy Market Size and Share Across Top Segments During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 23.09%, primarily driven by the rising breast cancer prevalence, and advancements in biomarker detection technologies Breast Cancer Liquid Biopsy Market report has reviews about key players in the market,...